N. Tanigawa et al., CORRELATION BETWEEN EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND TUMOR VASCULARITY, AND PATIENT OUTCOME IN HUMAN GASTRIC-CARCINOMA, Journal of clinical oncology, 15(2), 1997, pp. 826-832
Purpose: The relationship between the expression of vascular endotheli
al growth factor (VEGF) and its receptor, KDR, in human gastric carcin
oma tissues and tumor angiogenesis, as well as patient outcome, were i
nvestigated. Materials and Methods: One hundred sixty-three primary tu
mor specimens were investigated by immunohistochemical studies with an
ti-VEGF, anti-KDR, and anti-CD34 antibodies and by monitoring patients
for at least 2 years after surgery. Results: For intensity of VEGF st
aining, 48 tumors were graded as 0, 36 as 1+, 63 as 2+, and 16 as 3+.
Tumors with strong VEGF staining, assessed as 2+ and 3+, had significa
ntly higher vascularity than those with weak VEGF. Eighty-eight tumors
(54%) were positive for KDR. There was no association between KDR exp
ression and tumor vascularity. No close correlation was found between
VEGF and KDR expressions. The Cox propertional hazards model identifie
d intratumoral vessel count as the most significant and independent pr
ognostic factor among various clinicopathologic factors. In contrast,
overall survival rates for 84 patients with weak VEGF staining tumors
and 79 with strong VEGF staining tumors were not significantly differe
nt. Patients with tumors of either localized Borrmann types or well-di
fferentiated histologies, which are found more frequently in rumors wi
th strong VEGF staining, survived significantly longer than those with
tumors of either infiltrative Borrmann types or poorly differentiated
histologies. Conclusion: We suggest that expression of VEGF is more f
requently found in tumors with well-differentiated histology and ploys
a role in the promotion of angiogenesis in human gastric carcinomas.
(C) 1997 by American Society of Clinical Oncology.